Search research articles
Contact Us
Filters
Showing results (131-140 of 141) with videos related to
Page
of 15
Sort By:
Cancer Treatment Reports
|
December 1, 1982
Comparative trial of two teniposide-based combination chemotherapy regimens for the treatment of advanced malignant lymphomas
M J O'Connell, J Anderson, J M Merrill, et al.
Leukemia & Lymphoma
|
October 1, 1994
Long-term follow-up of a CHOP-based regimen with maintenance therapy and central nervous system prophylaxis in lymphoblastic non-Hodgkin's lymphoma
J P Colgan, J Andersen, T M Habermann, et al.
Blood
|
November 15, 1996
Prognostic implications of ploidy and proliferative activity in the diffuse, aggressive non-Hodgkin's lymphomas
J N Winter, J Andersen, D Variakojis, et al.
Blood
|
July 1, 1983
Malignant lymphoma, mixed cell type, diffuse
B N Nathwani, G E Metter, R A Gams, et al.
The American Journal of Pathology
|
March 1, 1990
The detection of Epstein-Barr virus in hairy cell leukemia cells by in situ hybridization
B C Wolf, A W Martin, R S Neiman, et al.
Annals of Hematology
|
October 1, 1992
The evaluation of low-dose cytarabine in the treatment of myelodysplastic syndromes: a phase-III intergroup study
K B Miller, K Kim, F S Morrison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1992
Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group study
H S Hochster, K M Kim, M D Green, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1987
Prospectively randomized clinical trial of three intensive chemotherapy regimens for the treatment of advanced unfavorable histology non-Hodgkin's lymphoma
M J O'Connell, D P Harrington, J D Earle, et al.
American Journal of Clinical Pathology
|
April 1, 1997
Posttransplantation lymphoproliferative disorders in bone marrow transplant recipients are aggressive diseases with a high incidence of adverse histologic and immunobiologic features
A Orazi, R A Hromas, R S Neiman, et al.
Pediatric Blood & Cancer
|
April 10, 2023
Identifying patterns of neurocognitive dysfunction through direct comparison of children with leukemia, central nervous system tumors, and sickle cell disease
Claire E Fraley, Jamie S Neiman, Charlotte R Feddersen, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 141) with videos related to
Sort By:
Page
of 15
Cancer Treatment Reports
|
December 1, 1982
Comparative trial of two teniposide-based combination chemotherapy regimens for the treatment of advanced malignant lymphomas
M J O'Connell, J Anderson, J M Merrill, et al.
Leukemia & Lymphoma
|
October 1, 1994
Long-term follow-up of a CHOP-based regimen with maintenance therapy and central nervous system prophylaxis in lymphoblastic non-Hodgkin's lymphoma
J P Colgan, J Andersen, T M Habermann, et al.
Blood
|
November 15, 1996
Prognostic implications of ploidy and proliferative activity in the diffuse, aggressive non-Hodgkin's lymphomas
J N Winter, J Andersen, D Variakojis, et al.
Blood
|
July 1, 1983
Malignant lymphoma, mixed cell type, diffuse
B N Nathwani, G E Metter, R A Gams, et al.
The American Journal of Pathology
|
March 1, 1990
The detection of Epstein-Barr virus in hairy cell leukemia cells by in situ hybridization
B C Wolf, A W Martin, R S Neiman, et al.
Annals of Hematology
|
October 1, 1992
The evaluation of low-dose cytarabine in the treatment of myelodysplastic syndromes: a phase-III intergroup study
K B Miller, K Kim, F S Morrison, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1992
Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group study
H S Hochster, K M Kim, M D Green, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1987
Prospectively randomized clinical trial of three intensive chemotherapy regimens for the treatment of advanced unfavorable histology non-Hodgkin's lymphoma
M J O'Connell, D P Harrington, J D Earle, et al.
American Journal of Clinical Pathology
|
April 1, 1997
Posttransplantation lymphoproliferative disorders in bone marrow transplant recipients are aggressive diseases with a high incidence of adverse histologic and immunobiologic features
A Orazi, R A Hromas, R S Neiman, et al.
Pediatric Blood & Cancer
|
April 10, 2023
Identifying patterns of neurocognitive dysfunction through direct comparison of children with leukemia, central nervous system tumors, and sickle cell disease
Claire E Fraley, Jamie S Neiman, Charlotte R Feddersen, et al.
Page
of 15